Martina McGrath is a Nephrology physician affiliated with Brigham and Women's Hospital. OpenAlex indexes 70 publications with 1,974 citations (h-index 26); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
75 Francis St
Brigham And Women'S Hospital
Boston, MA 021156110
Telephone
617-732-5897Registry record last updated 9 Dec 2013.
Clinical trials
- Sotagliflozin Safety and Tolerability Among Renal Transplant Recipients
Sponsor: Martina McGrath, MD
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Alexion Pharmaceuticals, Inc.Program year20251 payment
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
- Novo Nordisk IncProgram year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
49.8%Calcium channel blocker14.5%Amlodipine Besylate100%Part D≥24 patientsBeta blocker13.3%Carvedilol70%Metoprolol Succinate30%Part D<11 patients+ 3 more classes in this area
Metabolism & gastrointestinal
29.1%Corticosteroid14.7%Prednisone100%Part D≥17 patientsH2 blocker5%Famotidine100%Part D<11 patients+ 3 more classes in this area
Cancer & immunology
10.4%Calcineurin inhibitor8%Tacrolimus65%Envarsus Xr35%Part D<11 patientsPurine Antimetabolite2.4%Azathioprine100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Finerenone and eGFR Slope across Different Levels of Baseline Albuminuria and eGFR
Clinical Journal of the American Society of Nephrology
2025 - Acute Changes in Kidney Function and Outcomes Following an Acute Myocardial Infarction: Insights from PARADISE-MI
European Journal of Heart Failure
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Paul Ridker, MD
Brigham and Women's Hospital
Scott Solomon, MD
Brigham and Women's Hospital
Marc Pfeffer, MD
Brigham and Women's Hospital
Marc Sabatine, MD
Brigham and Women's Hospital
Andrew Levey, MD
Tufts Medical Center
Bertram Kasiske, MD
Hennepin Healthcare
Garabed Eknoyan, MD
Baylor College of Medicine
Lawrence Hunsicker, MD
University of Iowa
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”